mTOR, Mammalian target of rapamycin
Vendramin Pasquetti M, Meier L, Loureiro S, Ganzella M, Junges B, Barbieri Caus L, et al
Remarkably, HDL prevents the oxidation of LDL (Figure 10) and recent evidence suggests that this may occur through 4 distinct proteins circulating on HDL apoA-I (845,846), LCAT (847), lipoprotein-associated phospholipase A2 (Lp-PLA2)(848,849), and paraoxonase 1 (PON1) (430,846)
In 2018, the Amgen team updated a new invention patent titled "Methods for Treating or Ameliorating Metabolic Disorders Using a Gastric Inhibitory Polypeptide Receptor Antagonist Bound to a Glucagon-Like Peptide-1 Receptor Agonist Fusion Protein (WO2018237095A1)." In this patent, researchers have created a fusion by linking the carboxyl-terminal end of a GLP-1 analog to the amino-terminal end of either the light chain variable region or the heavy chain variable region of an antibody or its functional fragment capable of binding to the GIPR receptor
and High dose Vitamin C inj
When bacterial overgrowth damages the intestinal barrier, toxins such as lipopolysaccharides enter the bloodstream
